News from aptuit llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 07, 2016, 08:00 ET Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing

Activities have commenced for 3 gene therapy programs in rare disease indications GREENWICH, CT and CAMBRIDGE, MA, July 7, 2016 /CNW/ - Aptuit LLC, a premier global drug discovery and development...


Jun 01, 2016, 08:00 ET Aptuit Names Henning Steinhagen as EVP Drug Discovery and Development, and Site-Head Verona

GREENWICH, CT, June 1, 2016 /CNW/ - Jonathan Goldman, CEO of Aptuit LLC, announced today the appointment of Henning Steinhagen, PhD, as Executive Vice President Drug Discovery and Development, and...


May 10, 2016, 08:00 ET Aptuit Announces Acquisition of Kuecept Ltd

Expanding capabilities in formulation development to include specialist pre-formulation, formulation prototyping and formulation development services GREENWICH, CT, May 10, 2016 /CNW/ - Aptuit, LLC...


Apr 21, 2016, 08:00 ET Aptuit Announces Acquisition of Exquiron Biotech AG

Expands capabilities in discovery to include high throughput screening and other early discovery services GREENWICH, CT, April 21, 2016 /CNW/ - Aptuit, LLC today announced that it has acquired...


Feb 22, 2016, 09:00 ET Aptuit and Icagen Agree to Strategic Alliance

Alliance to Provide Drug Discovery Customers Access to Industry Leading Ion Channel and Transporter Technologies GREENWICH, CT, Feb. 22, 2016 /CNW/ - Aptuit LLC and Icagen, Inc. today announced a...


Dec 07, 2015, 08:00 ET Aptuit Announces 16M$ Investment in Capacity and Capability

Significant increase in headcount, new capabilities in discovery and incremental increase in capacity in CMC GREENWICH, CT, Dec. 7, 2015 /CNW/ - Aptuit LLC announced it has commenced a growth program ...


Nov 30, 2015, 08:00 ET Aptuit CEO, Jonathan Goldman, Joins the Columbia University Healthcare Advisory Board

GREENWICH, CT, Nov. 30, 2015 /CNW/ - We are very pleased to announce that Jonathan Goldman, CEO of Aptuit, has accepted a nomination to join the Columbia University Healthcare Advisory Board....


Jul 13, 2015, 11:00 ET Aptuit Announces Expansion of Integrated CMC Offering (Drug Substance and Drug Product) to Phase 3 and Commercial Scale

Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license GREENWICH, CT, July 13, 2015 /CNW/ - Aptuit LLC announced...


Apr 14, 2015, 12:18 ET Aptuit LLC and Axxam SpA announce Strategic Alliance for Integrated Drug Discovery Services

Aptuit LLC, a premier global drug discovery and development CRO and Axxam SpA, a leading discovery company with expertise in target biology and a broad range of early phase discovery solutions,...


Jan 09, 2015, 07:33 ET Aptuit to Divest Two Non-Core Sites; Facilitates Reinvestment and Accelerated Growth in Core Area of Integrated Solutions

Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has divested its aseptic clinical manufacturing site in Glasgow, UK to Albany Molecular Research, Inc. (NASDAQ: AMRI), and has entered...


Jun 11, 2014, 16:09 ET Aptuit LLC Targets Scandinavian Life Science Prospects at Stockholm Events

GREENWICH, Conn., June 11, 2014 /CNW/ - Aptuit LLC has made a significant outreach to life science companies in Scandinavia through two important events that were held in Stockholm, Sweden this May....


Jan 08, 2013, 12:24 ET Aptuit and Aegerion Sign Commercial API Supply Agreement

GREENWICH, Conn., Jan. 8, 2013 /CNW/ - Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that Aptuit and Aegerion Pharmaceuticals, Cambridge, Massachusetts, have signed a ...


Nov 13, 2012, 09:37 ET Aptuit and GSK Extend Strategic Partnership

GREENWICH, Conn., Nov. 13, 2012 /CNW/ - Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated...